The ICN is particularly emphasized the need to see the issue of falsified medicines as ‘a symptom of a larger problem’, namely a lack of access to high-quality, affordable and effective healthcare. The Council is encouraging the Member State Mechanism to engage with our campaign and to foster collaborative action with important stakeholders in the fight against fake medicines.
PRESS RELEASES & STATEMENTS
Substandard & Falsified Medicines Block The Way To Universal Health Coverage
If we had the opportunity to deliver a statement at the 152nd WHO Executive Board meeting, this is what we would have said in relation to Agenda item 5. Universal Health Coverage Substandard & Falsified Read more…